155 related articles for article (PubMed ID: 29189985)
1. Evaluation of the effect of the new methoxy-stilbenes on expression of receptors and enzymes involved in estrogen synthesis in cancer breast cells.
Licznerska B; Szaefer H; Wierzchowski M; Mikstacka R; Papierska K; Baer-Dubowska W
Mol Cell Biochem; 2018 Jul; 444(1-2):53-62. PubMed ID: 29189985
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol and its methoxy derivatives modulate the expression of estrogen metabolism enzymes in breast epithelial cells by AhR down-regulation.
Licznerska B; Szaefer H; Wierzchowski M; Sobierajska H; Baer-Dubowska W
Mol Cell Biochem; 2017 Jan; 425(1-2):169-179. PubMed ID: 27854074
[TBL] [Abstract][Full Text] [Related]
3. Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes.
Szaefer H; Licznerska B; Cykowiak M; Baer-Dubowska W
Pharmacol Rep; 2019 Dec; 71(6):1001-1005. PubMed ID: 31561186
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells.
Macpherson L; Matthews J
Cancer Lett; 2010 Dec; 299(2):119-29. PubMed ID: 20846786
[TBL] [Abstract][Full Text] [Related]
5. R-sulforaphane modulates the expression profile of AhR, ERα, Nrf2, NQO1, and GSTP in human breast cell lines.
Licznerska B; Szaefer H; Krajka-Kuźniak V
Mol Cell Biochem; 2021 Feb; 476(2):525-533. PubMed ID: 33064289
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
[TBL] [Abstract][Full Text] [Related]
7. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
8. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
Spink BC; Fasco MJ; Gierthy JF; Spink DC
J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
[TBL] [Abstract][Full Text] [Related]
9. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
Wihlén B; Ahmed S; Inzunza J; Matthews J
Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity.
Perdew GH; Hollingshead BD; Dinatale BC; Morales JL; Labrecque MP; Takhar MK; Tam KJ; Beischlag TV
J Pharmacol Exp Ther; 2010 Nov; 335(2):273-83. PubMed ID: 20716622
[TBL] [Abstract][Full Text] [Related]
12. A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol.
Wang Y; Ye L; Leung LK
Toxicology; 2008 Jun; 248(2-3):130-5. PubMed ID: 18462857
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor induced intratumoral aromatase in breast cancer.
Saito R; Miki Y; Hata S; Ishida T; Suzuki T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2017 Feb; 161(3):399-407. PubMed ID: 27900579
[TBL] [Abstract][Full Text] [Related]
14. Zinc finger nuclease-mediated knockout of AHR or ARNT in human breast cancer cells abolishes basal and ligand-dependent regulation of CYP1B1 and differentially affects estrogen receptor α transactivation.
Ahmed S; Wang A; Celius T; Matthews J
Toxicol Sci; 2014 Mar; 138(1):89-103. PubMed ID: 24299737
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
[TBL] [Abstract][Full Text] [Related]
17. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.
Hsieh TC; Wong C; John Bennett D; Wu JM
Int J Cancer; 2011 Dec; 129(11):2732-43. PubMed ID: 21225623
[TBL] [Abstract][Full Text] [Related]
18. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.
Fu J; Weise AM; Falany JL; Falany CN; Thibodeau BJ; Miller FR; Kocarek TA; Runge-Morris M
Breast Cancer Res Treat; 2010 Feb; 120(1):35-45. PubMed ID: 19308726
[TBL] [Abstract][Full Text] [Related]
19. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.
Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T
J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581
[TBL] [Abstract][Full Text] [Related]
20. Red Clover Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor (ER) Agonists Enhance Genotoxic Estrogen Metabolism.
Dunlap TL; Howell CE; Mukand N; Chen SN; Pauli GF; Dietz BM; Bolton JL
Chem Res Toxicol; 2017 Nov; 30(11):2084-2092. PubMed ID: 28985473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]